A98.0
Crimean-Congo hemorrhagic fever
Clinical Classification Guidelines
Inclusion Terms
- Central Asian hemorrhagic fever
Medical Intelligence & Overview
Crimean-Congo Hemorrhagic Fever (CCHF) is a severe viral illness that can cause bleeding, organ failure, and even death in some cases. It is transmitted by ticks or contact with infected animal or human blood and tissues. Recognized worldwide, CCHF is most common in parts of Africa, the Balkans, the Middle East, and Asia, including Central Asian regions. Due to its potential severity, awareness and prompt identification are key components of managing this disease.
Causes & Symptoms
Clinical Causes: Tick bites, especially from Hyalomma ticks Contact with blood or tissues of infected animals such as livestock, camels, or sheep Infection through contact with infected human blood or bodily fluids Trauma that exposes blood or tissues to the virus Rare cases of nosocomial (hospital-acquired) transmission
Key Symptoms: High fever developing within 1-3 days of exposure Severe headache and muscle aches Bleeding tendencies, including bruising, bleeding gums, or blood in vomit, urine, or stool Lowered blood pressure and shock in severe cases Fatigue, weakness, and malaise Nausea, vomiting, and abdominal pain In some cases, liver and kidney dysfunction may occur
Diagnostic & Treatment
Diagnosis Path: Diagnosing Crimean-Congo Hemorrhagic Fever involves a combination of medical history, physical examination, and laboratory testing. Blood tests can detect the presence of the virus using PCR (polymerase chain reaction) during early stages. Serological tests may identify antibodies against the virus in later stages. Laboratory analyses also focus on detecting signs of bleeding, organ dysfunction, and viral presence to confirm the diagnosis.
Treatment Protocols: There is no specific antiviral treatment universally approved for CCHF. Supportive care is essential and may include fluids, blood transfusions, and medications to control bleeding and symptoms. In some cases, the antiviral medication ribavirin has been used with varying success to help reduce viral replication. Hospitalization and isolation are necessary to prevent transmission, especially in severe cases. Preventive measures, such as avoiding tick bites and using protective clothing when in endemic areas, are vital for at-risk populations.
Clinical Advice & FAQs
Billing Guidance
Is A98.0 a billable ICD-10 code?
Yes, A98.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A98.0?
Clinical documentation must specify the nature of Crimean-Congo hemorrhagic fever and any associated comorbidities for accurate reporting.
Cite this Clinical Reference